A new study published in Nano Today reveals that nanoplastics, which are tiny plastic particles less than one micrometer in size, may cross the blood-brain barrier (BBB) cells. The research marks a significant advancement in understanding how nanoplastics might transfer in human blood and interact with biological systems.
Led by Dr. Fazel A. Monikh from the University of Padua and Dr. Šárka Lehtonen from the University of Eastern Finland, the international team of scientists investigated how nanoplastics made from polystyrene (PS) and polyvinyl chloride (PVC) behave in human plasma and their ability to cross the BBB. The researchers utilised a novel approach by embedding gadolinium, a rare earth metal, into the nanoplastics, allowing precise tracking and quantification of their movement and transformation within the human body.
Key findings from the study include:
- Immediate formation of a biological corona: Upon exposure to human plasma, nanoplastics rapidly attract a variety of biomolecules, forming a 'biological corona' that affects their behavior and interactions with cells.
- Permeation of the blood-brain barrier: The study demonstrated that both PS and PVC nanoplastics could cross the BBB, with PVC particles showing a higher penetration rate. However, the presence of a biological corona significantly reduced the amount of nanoplastics entering the brain.
The human blood-brain barrier (BBB) consists of a tightly packed layer of endothelial cells, surrounded by astrocytes and pericytes that restricts the passage of a variety of molecules and substances from the blood to the brain. According to the researchers, the penetration of nanoplastics through the BBB highlights the need for further research on their potential neurotoxicity and long-term effects on human health.
Dr. Lehtonen commented, "Our research provides crucial insights into the behavior of nanoplastics in human biological systems. Understanding how these particles cross the blood-brain barrier opens new avenues for developing preventive measures against their potential harm."
The study represents a significant step forward in the field of nanotoxicology. The innovative methods and findings are expected to be instrumental in shaping future research and regulations regarding nanoplastic pollution and its impact on human health.
Te study was a collaborative effort among researchers from various institutions, including the University of Padua, University of Eastern Finland, Helmholtz Centre for Environmental Research GmbH, and the University of Birmingham, among others.
For further information, please contact:
Dr. Fazel A. Monikh, University of Padua, fazel.monikh@unipd.it
Dr. Šárka Lehtonen, University of Eastern Finland, sarka.lehtonen@uef.fi, https://uefconnect.uef.fi/en/person/sarka.lehtonen/
Research article:
Fazel Abdolahpur Monikh, Šárka Lehtonen, Jukka Kekäläinen, Isabel Karkossa, Seppo Auriola, Kristin Schubert, Alessandra Zanut, Sanni Peltonen, Jonna Niskanen, Mandar Bandekar, Martin von Bergen, Jari T.T. Leskinen, Arto Koistinen, Sara Bogialli, Zhiling Guo, Jussi V.K. Kukkonen, Chunying Chen, Iseult Lynch, Biotransformation of nanoplastics in human plasma and their permeation through a model in vitro blood-brain barrier: An in-depth quantitative analysis, Nano Today, Volume 59, 2024, 102466, ISSN 1748-0132, https://www.sciencedirect.com/science/article/pii/S1748013224003220
